|
1
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 36:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Zeng Q and Hong W: The emerging role of
the hippo pathway in cell contact inhibition, organ size control
and cancer development in mammals. Cancer Cell. 13:188–192. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in
Drosophila and mammals. Cell. 130:1120–1133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Ma L, Weng W, Qiao Y, Zhang Y, He
J, Wang H, Xiao W, Li L, Chu Q, et al: Mutual interaction between
YAP and CREB promotes tumorigenesis in liver cancer. Hepatology.
58:1011–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu
J, Lin JD, Wang CY, Chinnaiyan AM, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Urtasun R, Latasa MU, Demartis MI, Balzani
S, Goñi S, Garcia-Irigoyen O, Elizalde M, Azcona M, Pascale RM, Feo
F, et al: Connective tissue growth factor autocriny in human
hepatocellular carcinoma: Oncogenic role and regulation by
epidermal growth factor receptor/yes-associated protein-mediated
activation. Hepatology. 54:2149–2158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wolfe A, Septer S, Edwards G, Zhong
X, Abdulkarim AB, Ranganathan S and Apte U: Deregulation of Hippo
kinase signalling in human hepatic malignancies. Liver Int.
32:38–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Tang X, Weng W, Qiao Y, Lin J, Liu
W, Liu R, Ma L, Yu W, Yu Y, et al: The membrane protein melanoma
cell adhesion molecule (MCAM) is a novel tumor marker that
stimulates tumorigenesis in hepatocellular carcinoma. Oncogene.
34:5781–5795. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Park JS, Wei Y, Rajurkar M, Cotton
JL, Fan Q, Lewis BC, Ji H and Mao J: TRIB2 acts downstream of
Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.
Mol Cell. 51:211–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johannessen M, Delghandi MP and Moens U:
What turns CREB on? Cell Signal. 16:1211–1227. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Dam H and Castellazzi M: Distinct
roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene.
20:2453–2464. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benbrook DM and Jones NC: Heterodimer
formation between CREB and JUN proteins. Oncogene. 5:295–302.
1990.PubMed/NCBI
|
|
17
|
Mayr B and Montminy M: Transcriptional
regulation by the phosphorylation-dependent factor CREB. Nat Rev
Mol Cell Biol. 2:599–609. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Böhm M, Moellmann G, Cheng E,
Alvarez-Franco M, Wagner S, Sassone-Corsi P and Halaban R:
Identification of p90RSK as the probable CREB-Ser133 kinase in
human melanocytes. Cell Growth Differ. 6:291–302. 1995.PubMed/NCBI
|
|
19
|
Chrivia JC, Kwok RP, Lamb N, Hagiwara M,
Montminy MR and Goodman RH: Phosphorylated CREB binds specifically
to the nuclear protein CBP. Nature. 365:855–859. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kundu TK, Palhan VB, Wang Z, An W, Cole PA
and Roeder RG: Activator-dependent transcription from chromatin in
vitro involving targeted histone acetylation by p300. Mol Cell.
6:551–561. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smalley KS: A pivotal role for ERK in the
oncogenic behaviour of malignant melanoma? Int J Cancer.
104:527–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okazaki K and Sagata N: The Mos/MAP kinase
pathway stabilizes c-Fos by phosphorylation and augments its
transforming activity in NIH 3T3 cells. EMBO J. 14:5048–5059.
1995.PubMed/NCBI
|
|
23
|
Murphy LO, Smith S, Chen RH, Fingar DC and
Blenis J: Molecular interpretation of ERK signal duration by
immediate early gene products. Nat Cell Biol. 4:556–564.
2002.PubMed/NCBI
|
|
24
|
Mao L, Yang L, Tang Q, Samdani S, Zhang G
and Wang JQ: The scaffold protein Homer1b/c links metabotropic
glutamate receptor 5 to extracellular signal-regulated protein
kinase cascades in neurons. J Neurosci. 25:2741–2752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
